Latest from Pharmaceuticals

Inside the fentanyl trade powering the world’s deadliest drug crisis

Times: Last year the drug killed more young Americans than car accidents or guns.

Revealed: David Seymour's big plans for Pharmac

Seymour wants investigation of possible cost-sharing between Pharmac and patients.

Relapse risk: Schizophrenia meds in supply crunch

Psychiatrists say disruption could cause some patients to suffer relapse of psychosis.

Hope for cancer patients as price falls on life-extending drug

The scheme won't cover all multiple myeloma patients. Details are due within a month.

'Wonderful doctor' sells family home to buy blood cancer drugs

Dr Logan McLennan's former patients are stepping forward to help the beloved GP.

Pharmac stops free flu vaccines for older Māori, Pasifika

Lady Tureiti Moxon says the decision is ‘another anti-Maōri stance’.

Is Alzheimer's the same as dementia? A brain expert explains

Telegraph: Professor Tara Spires-Jones on causes, symptoms, diagnosis and treatment.

'Deliberate deception': Pharmacist ordered extra meds, then sold them online

Jayant Patel was caught when the pharmacy owner noticed extra medication and viewed CCTV.

Oprah says she's on a weight-loss drug and ‘done with the shaming’

New York Times: 'I have a predisposition that no amount of willpower is going to control.'

Chemist Warehouse eyed up in huge merger bid

Brash newcomer would merge to create huge new pharmacy company.

Iwi leader fears lifting pseudoephedrine ban will put more P on the streets

'You’re not doing your country any good to put it on the shelves.'

Jarrod Gilbert: The good drugs are returning to chemists

OPINION: The damage caused by stopping pseudoephedrine has been done.

'Fantastic news': Mum cancer-free after international medical trial

Hamilton woman Lisa Martin was among those whose aggressive cancer was eliminated.

Focus Live: Coalition Govt agrees to allow the sale of Pseudoephedrine

Act leader David Seymour at the signing of the coalition agreement with National and NZ First says pseudoephedrine will be back on shelves in time for next winter. Video / Mark Mitchell

Ebos Group's pet project is off, shares fall sharply as trading resumes

Ebos had been in a trading halt since last week.

Menopause checklist: Questions to ask your doctor about HRT

Telegraph: Considering hormone replacement therapy? Here's what you need to know.